ArticleACS omega2017
Covalent-Bonded Reduced Graphene Oxide-Fluorescein Complex as a Substrate for Extrinsic SERS Measurements.
Article in ACS omega, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
When graphene is used as SERS substrates, it contributes to the chemical mechanism (CM) of enhancement of Raman signal, owing to which the detection limit is very low (lower than mM content of probe molecules). The CM of enhancement depends largely on the interactions between the substrate and the probe molecules. Therefore, in this work, we have investigated the possibility of increasing the SERS activity of graphene by improving the interaction between the probe molecule and the graphene substrate by establishing exclusively strong covalent bonding between them. Fluorescein (Fl) was selected as a probe molecule because it is one of the most commonly used fluorophore in bioscience. As a graphene substrate, reduced graphene oxide (rGO) platelets were used. In addition, silver nanoparticles (AgNPs) were added onto the hybrids to further increase the enhancement by electromagnetic mechanism. Highly enhanced Raman signal of Fl onto neat rGO was achieved for micromolar concentration of the probe molecules. This was attributed to the covalent bonding between them, which introduced hole doping to rGO, decreasing the Fermi level of rGO and bringing it more closely to the LUMO of Fl. This induces aligning of their energy levels, resulting in higher contribution of the nonresonance effect to the charge transfer mechanism of enhancement, which, in this case, occurred intramolecularly. When AgNPs were added onto the rGO substrate, the expected enhancement performance was not observed. On the one hand, this was attributed to small size (∼20 nm) of AgNPs and lack of aggregates and, on the other, due to the unusually high contribution of CM determined.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.